5 results about "Ocular hypertension" patented technology

To provide ophthalmic devices and methods for treating glaucoma, ocular hypertension (OHT), and other diseases. [Solution] The system (20) comprises a radiation source (48) and a controller (44), the controller being configured to: display a live sequence of images of the patient's (22) eye (25); while displaying the sequence of images of the eye, to direct the radiation source to irradiate the eye with one or more targeting beams (84) visible in the images; after directing the targeting beams to the eye with the radiation source, to receive confirmation input from the user; and in response to receiving confirmation input, to treat the eye by directing the radiation source to irradiate each target area of ​​the eye with multiple treatment beams. Other embodiments are also described.

Prostamide-containing intraocular implants that biodegrade in the eye and that are effective for reducing intraocular pressure in an eye for a sustained period. The implants generally contain a prostamide, such as bimatoprost, and at least three distinct biodegradable polymers selected from polylactide and poly(lactide-co-glycolide) polymers and are optimized for placement in and compatibility with the anterior chamber of the eye, particularly the anterior chamber angle. Methods for making and using the implants to reduce ocular hypertension and intraocular pressure in a patient are described.

Nitric oxide releasing phosphodiesterase type 5 (PDE5) inhibitors of formula (I) or (Ib) or (II) or a stereoisomer or a pharmaceutically acceptable salt thereof:useful for the treatment of ocular condition associated with elevated intraocular pressure such as ocular hypertension, glaucoma or retinopathies. Also disclosed are 3-[(2S)-2,3-bis(nitrooxy)propoxy]propanoic acid and 6-(nitrooxy)hexanoic acid for use in the treatment of ocular condition associated with elevated intraocular pressure such as ocular hypertension, glaucoma or retinopathies.

To provide ophthalmic devices and methods for treating glaucoma, ocular hypertension (OHT), and other diseases. [Solution] The system comprises a radiation source (48) and a controller (44). The controller is configured to: designate multiple target regions (84) of the patient's (22) eye (25) to irradiate with different amounts of energy; cause the radiation source to irradiate at least a first target region of the multiple target regions; after causing the radiation source to irradiate at least a first target region of the multiple target regions, process an image of the eye to identify changes in the eye; and in response to the identification of changes in the eye, cause the radiation source to refrain from irradiating a second target region of the multiple target regions that have not yet been irradiated with the amount of energy specified for the second target region. Other embodiments are also described.